Schneeberger, Emilce Edith https://orcid.org/0000-0001-7671-5748
Perandones, Miguel
Rosemffet, Marcos Gabriel
Otaola, María
Cazenave, Tomás
Barbich, Tatiana
Abarza, Virginia Carrizo
Balcazar, Jonathan
Citera, Gustavo
Funding for this research was provided by:
Pfizer (#66531681)
Article History
Received: 13 February 2025
Revised: 18 May 2025
Accepted: 21 May 2025
First Online: 24 June 2025
Change Date: 3 December 2025
Change Type: Update
Change Details: The original online version of this article was revised: In the original version of this article, the given and family names of all authors were incorrectly structured. The names were displayed incorrectly in all versions at the time of publication.
Change Date: 5 December 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10067-025-07844-8
Declarations
:
: - Schneeberger Emilce Edith. Speaker, advisor, and/or received grants from Amgen, AbbVie, Bristol-Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer, Raffo.- Perandones Miguel. No disclosures- Rosemffet Marcos Gabriel. Speaker, advisor, and/or received grants from Abbvie, Raffo- Otaola María. Speaker, advisor, and/or received grants from Boehringer Ingelheim, Bristol Myers Squibb, Tuteur, Raffo- Cazenave Tomás. No disclosures- Barbich Tatiana.- Carrizo Abarza Virginia. No disclosures- Balcazar Jonathan. No disclosures- Citera Gustavo. Speaker, advisor, and/or received grants from Amgen, Abbvie, Bago, BioSidus, Bristol-Myers Squibb, Janssen, Pfizer, Raffo